相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。被撤回的出版物: Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma:: results of a multicenter randomized clinical trial (Retracted article. See vol. 113, pg. 6265, 2009)
Abderrahman Abdelkefi et al.
BLOOD (2008)
Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplant
Muzaffar H. Qazilbash et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial
Pieter Sonneveld et al.
HAEMATOLOGICA (2007)
Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study
Michele Cavo et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma
Ka Lung Wu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trials
John Koreth et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis
N. C. Gutierrez et al.
LEUKEMIA (2007)
Validity of composite end points in clinical trials
VM Montori et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation
H Chang et al.
BLOOD (2005)
Single versus double autologous stem-cell transplantation for multiple myeloma
M Attal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Hypodiploidy is a major prognostic factor in multiple myeloma
NV Smadja et al.
BLOOD (2001)
Systematic reviews in health care -: Assessing the quality of controlled clinical trials
P Jüni et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
The revised CONSORT statement for reporting randomized trials: Explanation and elaboration
DG Altman et al.
ANNALS OF INTERNAL MEDICINE (2001)
分享论文
